ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 27.28

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.60K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.30 (+0.96%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.35 (+1.28%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.10 (-0.40%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.34 (+1.01%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+1.09 (+2.47%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.18 (-0.63%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.07 (+0.65%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.04 (+0.18%)

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.41% 48% F 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.41% 48% F 45% F
Trailing 12 Months  
Capital Gain -6.13% 17% F 25% F
Dividend Return 3.85% 80% B- 70% C-
Total Return -2.27% 21% F 26% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.01% 41% F 40% F
Dividend Return 3.03% 43% F 36% F
Total Return 1.02% 82% B 38% F
Risk Return Profile  
Volatility (Standard Deviation) 4.53% 84% B 93% A
Risk Adjusted Return 66.73% 74% C 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.